StockNews.com upgraded shares of Avanos Medical (NYSE:AVNS – Free Report) from a buy rating to a strong-buy rating in a report published on Tuesday morning.
Avanos Medical Stock Down 1.2 %
Shares of NYSE:AVNS opened at $23.32 on Tuesday. The firm’s 50 day moving average price is $23.47 and its 200 day moving average price is $21.34. The stock has a market cap of $1.07 billion, a price-to-earnings ratio of -17.53 and a beta of 0.91. Avanos Medical has a fifty-two week low of $17.24 and a fifty-two week high of $25.36. The company has a quick ratio of 1.49, a current ratio of 2.28 and a debt-to-equity ratio of 0.13.
Avanos Medical (NYSE:AVNS – Get Free Report) last issued its earnings results on Wednesday, July 31st. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.05. The firm had revenue of $171.70 million for the quarter, compared to analysts’ expectations of $170.67 million. Avanos Medical had a net margin of 1.13% and a return on equity of 4.48%. The firm’s revenue was up 1.4% compared to the same quarter last year. During the same quarter last year, the company earned $0.24 earnings per share. As a group, equities research analysts predict that Avanos Medical will post 1.39 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Avanos Medical
About Avanos Medical
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Articles
- Five stocks we like better than Avanos Medical
- Why Invest in 5G? How to Invest in 5G Stocks
- Survey Reveals: America’s Most Coveted Businesses in 2024
- Conference Calls and Individual Investors
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.